Literature DB >> 15499000

Genetics. The critical region in trisomy 21.

David L Nelson1, Richard A Gibbs.   

Abstract

Mesh：

Year:  2004        PMID： 15499000     DOI： 10.1126/science.1105226

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

Review 1.  Cellular reprogramming: a new technology frontier in pharmaceutical research.

Authors:  Amy Brock; Hui-Tong Goh; Binxia Yang; Yu Lu; Hu Li; Yuin-Han Loh
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

2.  Bilateral semilunar valve dysplasia in a patient with inverted duplication 2p25-22.

Authors:  L K Kochilas; D N Abuelo; U Tantravahi
Journal:  Pediatr Cardiol       Date:  2007-08-04       Impact factor: 1.655

Review 3.  Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells.

Authors:  M William Lensch; George Q Daley
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

Review 4.  Mouse models of Down syndrome: gene content and consequences.

Authors:  Meenal Gupta; A Ranjitha Dhanasekaran; Katheleen J Gardiner
Journal:  Mamm Genome       Date:  2016-08-18       Impact factor: 2.957

Review 5.  Technical challenges in using human induced pluripotent stem cells to model disease.

Authors:  Krishanu Saha; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

6.  Disease-specific induced pluripotent stem cells.

Authors:  In-Hyun Park; Natasha Arora; Hongguang Huo; Nimet Maherali; Tim Ahfeldt; Akiko Shimamura; M William Lensch; Chad Cowan; Konrad Hochedlinger; George Q Daley
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

7.  Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21.

Authors:  Víctor Rodríguez-Sureda; Ángel Vilches; Olga Sánchez; Laura Audí; Carmen Domínguez
Journal:  Oxid Med Cell Longev       Date:  2015-03-17       Impact factor: 6.543

8.  Systematic reanalysis of partial trisomy 21 cases with or without Down syndrome suggests a small region on 21q22.13 as critical to the phenotype.

Authors:  Maria Chiara Pelleri; Elena Cicchini; Chiara Locatelli; Lorenza Vitale; Maria Caracausi; Allison Piovesan; Alessandro Rocca; Giulia Poletti; Marco Seri; Pierluigi Strippoli; Guido Cocchi
Journal:  Hum Mol Genet       Date:  2016-04-22       Impact factor: 6.150

9.  An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes.

Authors:  Aideen O'Doherty; Sandra Ruf; Claire Mulligan; Victoria Hildreth; Mick L Errington; Sam Cooke; Abdul Sesay; Sonie Modino; Lesley Vanes; Diana Hernandez; Jacqueline M Linehan; Paul T Sharpe; Sebastian Brandner; Timothy V P Bliss; Deborah J Henderson; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher
Journal:  Science       Date:  2005-09-23       Impact factor: 63.714
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.